Company performance
Add to research
Current Price
as of Apr 21, 2025$3.03
P/E Ratio
N/A
Market Cap
$82.92M
Description
Add to research
iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment includes image analysis and workflow products. The Cancer Therapy segment relates to radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH.
Metrics
Add to research
Overview
- HQNashua, NH
- SectorHealth Technology
- IndustryMedical Specialties
- TickerICAD
- Price$3.03-5.90%
Trading Information
- Market cap$82.92M
- Float94.29%
- Average Daily Volume (1m)1,526,142
- Average Daily Volume (3m)888,203
- EPS-$0.21
Company
- Revenue$19.61M
- Rev growth (1yr)13.22%
- Net income-$5.62M
- Gross margin83.60%
- EBITDA margin-27.85%
- EBITDA-$5.46M
- EV$31.38M
- EV/Revenue1.60
- P/EN/A
- P/S4.07
- P/B2.78
- Debt/Equity1.26
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account
Factset